Personalized Medicine Coalition

Company

Related News

mRNA Vaccine Market Projected to Reach $82.61 Billion by 2030 Amid Safety Debates

Mar 04, 2026

The global mRNA and next-generation vaccine platforms market is expected to grow from $39.69 billion in 2025 to $82.61 billion by 2030 at a 15.8% CAGR, driven by personalized medicine demand and infectious disease applications, while safety concerns and regulatory scrutiny continue.

AI Transforms Drug Discovery as Market Reaches $31.5 Billion and Phase III Trials Loom

Feb 16, 2026

The drug development services market is projected to reach $31.5 billion in 2026, growing at 12.2% CAGR, while AI-designed drugs enter pivotal Phase III trials that will determine whether the technology can improve clinical success rates beyond the industry's persistent 90% failure rate.